We used Crisp-Cas9 gene editing to construct a BGC-823 cell line with a stable knockdown of CPNE3, CDX, and PDX, which showed that targeting CPNE3 significantly inhibited tumor growth. The gene discussed is CPNE3; the disease is neoplasm.